Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold

被引：36

作者：

Jones, Eric D. ^{[1
]}

Vandegraaff, Nick ^{[1
]}

Le, Giang ^{[1
]}

Choi, Neil ^{[1
]}

Issa, William ^{[1
]}

Macfarlane, Katherine ^{[1
]}

Thienthong, Neeranat ^{[1
]}

Winfield, Lisa J. ^{[1
]}

Coates, Jonathan A. V. ^{[1
]}

Lu, Long ^{[2
]}

Li, Xinming ^{[2
]}

Feng, Xiao ^{[2
]}

Yu, Changjiang ^{[2
]}

Rhodes, David I. ^{[1
]}

Deadman, John J. ^{[1
]}

机构：

[1] Avexa Ltd, Richmond, Vic 3121, Australia

[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 19期

关键词：

Integrase; Inhibitor; Synthesis; 3-Hydroxy-pyrido[12-a]pyrimidin-4-one;

D O I：

10.1016/j.bmcl.2010.07.079

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

HIV integrase inhibitors based on a novel bicyclic pyrimidinone core is presented. Nine variations of the core scaffold are evaluated leading to optimization of the 6:6 core giving compound 48 with an EC50 of 3 nM against wild type HIV infected T-cells. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5913 / 5917

页数：5

共 50 条

[41] 1,3-Diketo analogs as HIV integrase inhibitors.
Pais, GCG
Neamati, N
Pommier, Y
Burke, TR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U551 - U551
[42] Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 1. Molecular Design and Establishment of an Advanced Two-Metal Binding Pharmacophore
Kawasuji, Takashi
Johns, Brian A.
Yoshida, Hiroshi
Taishi, Teruhiko
Taoda, Yoshiyuki
Murai, Hitoshi
Kiyama, Ryuichi
Fuji, Masahiro
Yoshinaga, Tomokazu
Seki, Takahiro
Kobayashi, Masanori
Sato, Akihiko
Fujiwara, Tamio
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (20) : 8735 - 8744
[43] Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
Meixenberger, Karolin
Yousef, Kaveh Pouran
Somogyi, Sybille
Fiedler, Stefan
Bartmeyer, Barbara
von Kleist, Max
Kuecherer, Claudia
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 157 - 157
[44] 1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position
Johns, Brian A.
Weatherhead, Jason G.
Allen, Scott H.
Thompson, James B.
Garvey, Edward P.
Foster, Scott A.
Jeffrey, Jerry L.
Miller, Wayne H.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1807 - 1810
[45] Comparative QSAR as a cheminformatics tool in the design of HIV-1 protease inhibitors.
Garg, R
Bhhatarai, B
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U778 - U779
[46] Oligonucleotide inhibitors of HIV-1 integrase efficiently inhibit HIV-1 reverse transcriptase
S. P. Korolev
T. S. Zatsepin
M. B. Gottikh
Russian Journal of Bioorganic Chemistry, 2017, 43 : 135 - 139
[47] Oligonucleotide Inhibitors of HIV-1 Integrase Efficiently Inhibit HIV-1 Reverse Transcriptase
Korolev, S. P.
Zatsepin, T. S.
Gottikh, M. B.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2017, 43 (02) : 135 - 139
[48] Molecular modeling of HIV-1 protease inhibitors.
Castillo, H
Parish, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U298 - U298
[49] QSAR studies of HIV-1 protease inhibitors.
Garg, R
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U908 - U908
[50] Comparing the conformational flexibility of HIV-1 inhibitors.
James, J
Pratt, J
Schram, K
Parish, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U492 - U492

← 1 2 3 4 5 →